tag:U.S. Food and Drug Administration

Beekeeper’s Naturals has issued a voluntary recall for 585 units of its Saline Nasal Spray after tests revealed microbiological contamination, including yeast and potential Aspergillus mold. According to a June 12, 2026, announcement posted on the Food and Drug Administration (FDA) website, the recalled products were sold on Amazon between April 2 and April 24, 2026. The company has received four reports of adverse reactions linked to the product.

Which specific products are affected by the recall?

The recall is limited to a single specific batch of Beekeeper’s Naturals Saline Nasal Spray. Consumers should check the bottom of their 1-fluid-ounce (30 mL) bottles for the following identifiers:

Lot Number: 5950
Expiration Date: February 2028

The affected bottles feature a distinctive brown plastic design with a yellow cap and label. According to the company, other products in their line, such as the Nasal Spray Max, are not included in this recall. Consumers who possess a bottle with the matching lot number should discontinue use immediately.

Pro Tip: Always keep product packaging until you have verified the lot number against official FDA recall notices. If you cannot find the lot number, contact the manufacturer directly before using the product.

What are the health risks of mold contamination?

The primary concern regarding this recall is the presence of Aspergillus, a fungus commonly found in soil that can lead to a condition known as aspergillosis. According to George Washington University, exposure to this mold through a nasal product can be particularly dangerous for individuals with weakened immune systems or underlying lung diseases.

The company stated that the contamination could lead to “serious and life-threatening infections,” including invasive sinusitis and lung infections. The Mayo Clinic notes that common symptoms of such infections include shortness of breath, cough, and fever; in severe cases, patients may cough up blood.

How to get a refund and report adverse reactions

Beekeeper’s Naturals is providing refunds to customers who purchased the impacted lot. To initiate a claim, customers can contact the company via email at [email protected] or by phone at 1-888-759-6910.

If you believe you have experienced health issues related to the spray, contact your healthcare provider immediately. You may also report the adverse event to the FDA’s MedWatch program. Reports can be filed by faxing a form to 1-800-332-0178 or by submitting a report through the FDA MedWatch website.

Did you know? While reporting to the FDA is voluntary for consumers, it provides critical data that helps regulators identify trends in manufacturing failures and protect the broader public from contaminated goods.

Frequently Asked Questions

Can I continue using other Beekeeper’s Naturals products?

Yes. The recall is specific only to lot 5950 of the Saline Nasal Spray. Other products, including Nasal Spray Max, are not affected.

REVIEWING Beekeeper's Naturals PROPOLIS Immune Support Throat Spray

What if I already used some of the spray?

Discontinue use immediately. If you have not experienced symptoms, monitor your health for signs of respiratory distress or fever and consult your physician if you are concerned.

Is this a nationwide recall?

The product was sold through Amazon, which distributes nationwide. The company is managing the recall process in coordination with the FDA to ensure all affected units are removed from circulation.

Have you checked your medicine cabinet for the affected lot? Share your experience in the comments below or subscribe to our newsletter for the latest updates on consumer safety and product recalls.

Delaware patients with private health insurance may soon see expanded access to mental health and substance use disorder treatment under the Fair Standards Mental Health Care Act. The legislation, which passed both the state House and Senate in June 2026, mandates that insurers adopt evidence-based clinical standards and eliminates many prior authorization hurdles for mental wellness services, according to the bill’s text.

How the Fair Standards Mental Health Care Act Changes Coverage

The act aims to close the gap between mental health coverage and traditional medical services by requiring insurance carriers to align their policies with independent, clinical “gold-standard” guidelines. According to the bill, this includes standards set by organizations like the American Academy of Child and Adolescent Psychiatry. Insurers will be required to cover all medically necessary services, including emergency care and inpatient treatment, without the bureaucratic delays often associated with prior authorization.

Did you know?
Delawareans are currently five times more likely to seek out-of-network mental health care compared to primary care, leading to significantly higher out-of-pocket costs for families, according to data cited in the legislation.

What Defines “Serious Mental Illness” Under the New Rules?

Following the passage of House Amendment 1 on June 9, 2026, the law creates a distinction between general mental health care and “serious mental illness.” Under the amendment, carriers may still require precertification or prior authorization for disorders not classified as “serious.” Legislators defined serious mental illness to include conditions such as schizophrenia, bipolar disorder, eating disorders, and neurodevelopmental disorders, among others. Diagnostic criteria must be determined using the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders.

Why Parity Matters for Patients

The legislation introduces a “nonquantitative treatment limitation parity analysis,” a process that forces health plans to prove that barriers like step therapy are no more restrictive for mental health than they are for surgical or medical benefits. According to the U.S. Department of Labor, this documentation must be provided to providers and patients free of charge upon request. By requiring this transparency, the state aims to stop the common practice of families paying out-of-pocket for services that should be covered by their existing insurance premiums.

Delaware Gov. John Carney Signs Bill To Support Doctors That Get Mental Health Treatment

Pro Tip:
If you struggle to get mental health coverage approved, ask your insurer for their “nonquantitative treatment limitation” documentation. Under this new state framework, they are required to justify why mental health limits are stricter than those applied to physical health procedures.

What Happens Next for Delaware Policyholders?

The bill currently awaits the signature of Gov. Meyer. If enacted, the requirements will apply to individual, group, and blanket policies issued or renewed after December 31, 2027. The law also mandates that at least one FDA-approved medication for substance use disorders must be placed on the lowest-cost tier of drug formularies, ensuring that life-saving treatments remain affordable for those in recovery.

Frequently Asked Questions

When does the new law take effect?
If signed by the governor, the provisions apply to insurance contracts renewed or issued after December 31, 2027.
Does this affect all health insurance plans?
The act covers individual, group, and blanket policies operating within the state.
Can insurers still require prior authorization?
Yes, for conditions not classified as “serious mental illness,” carriers may still require screening or prior authorization, provided they meet the new parity standards.

Have questions about how this legislation might impact your specific health plan? Leave a comment below or subscribe to our newsletter for updates on Delaware healthcare policy.